Private Capital Group’s Corcept Therapeutics CORT Stock Holding History

Private Capital Group’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Hold	43	–	–	﹤0.01%	1679
2022 Q1	$1K	Hold	43	–	–	﹤0.01%	1912
2021 Q4	$1K	Hold	43	–	–	﹤0.01%	1914
2021 Q3	$1K	Hold	43	–	–	﹤0.01%	1972
2021 Q2	$1K	Hold	43	–	–	﹤0.01%	1950
2021 Q1	$1K	Hold	43	–	–	﹤0.01%	1854
2020 Q4	$1K	Hold	43	–	–	﹤0.01%	1877
2020 Q3	$1K	Hold	43	–	–	﹤0.01%	1820
2020 Q2	$1K	Hold	43	–	–	﹤0.01%	1807
2020 Q1	$1K	Sell	43 -10	-19%	-$124	﹤0.01%	1772
2019 Q4	$0	Buy	53 +21	+66%	+$292	﹤0.01%	2011
2019 Q3	$1K	Sell	32 -2,631	-99%	-$32.3K	﹤0.01%	2008
2019 Q2	$42K	Buy	+2,663	New	+$29.7K	0.01%	747
2019 Q1	–	Sell	-2,836	Closed	-$38K	–	2218
2018 Q4	$38K	Buy	2,836 +2,112	+292%	+$27.9K	0.01%	793
2018 Q3	$10K	Sell	724 -1,939	-73%	-$27.1K	﹤0.01%	1449
2018 Q2	$41K	Hold	2,663	–	–	0.01%	783
2018 Q1	$44K	Buy	+2,663	New	+$49.3K	0.01%	734

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Capital Group's CORT Position: Q2 2022 in Review

Private Capital Group held its Corcept Therapeutics (CORT) position steady in Q2 2022 at 43 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1679.

Private Capital Group first reported a position in CORT in Q1 2018 and has held it in 17 quarters since. The position peaked at $44K in Q1 2018. 225 funds tracked by Wall St. Rank hold CORT as of Q2 2022.

Private Capital Group held 43 shares of Corcept Therapeutics worth $1K as of Q2 2022.
Private Capital Group left its Corcept Therapeutics share count unchanged in Q2 2022.
Corcept Therapeutics made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1679 holding.
Private Capital Group first reported a position in Corcept Therapeutics in Q1 2018 and has held it in 17 quarters since.
Private Capital Group's Corcept Therapeutics position peaked at $44K in Q1 2018.
225 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.